216 related articles for article (PubMed ID: 33679786)
1.
Cascalho M; Platt JL
Front Immunol; 2021; 12():634544. PubMed ID: 33679786
[TBL] [Abstract][Full Text] [Related]
2. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development.
Romberg N; Virdee M; Chamberlain N; Oe T; Schickel JN; Perkins T; Cantaert T; Rachid R; Rosengren S; Palazzo R; Geha R; Cunningham-Rundles C; Meffre E
J Allergy Clin Immunol; 2015 Nov; 136(5):1315-25. PubMed ID: 26100089
[TBL] [Abstract][Full Text] [Related]
3. TACI is mutant in common variable immunodeficiency and IgA deficiency.
Castigli E; Wilson SA; Garibyan L; Rachid R; Bonilla F; Schneider L; Geha RS
Nat Genet; 2005 Aug; 37(8):829-34. PubMed ID: 16007086
[TBL] [Abstract][Full Text] [Related]
4. TACI mutation in common variable immunodeficiency and IgA deficiency.
Rachid R; Castigli E; Geha RS; Bonilla FA
Curr Allergy Asthma Rep; 2006 Sep; 6(5):357-62. PubMed ID: 16899196
[TBL] [Abstract][Full Text] [Related]
5. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
Lee JJ; Ozcan E; Rauter I; Geha RS
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and clinical heterogeneity associated with monoallelic TNFRSF13B-A181E mutations in common variable immunodeficiency.
Dong X; Hoeltzle MV; Hagan JB; Park MA; Li JT; Abraham RS
Hum Immunol; 2010 May; 71(5):505-11. PubMed ID: 20156508
[TBL] [Abstract][Full Text] [Related]
7. Three different classifications, B lymphocyte subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms in Turkish patients with common variable immunodeficiency.
Kutukculer N; Gulez N; Karaca NE; Aksu G; Berdeli A
J Clin Immunol; 2012 Dec; 32(6):1165-79. PubMed ID: 22699762
[TBL] [Abstract][Full Text] [Related]
8. TNFRSF13B/TACI alterations in Greek patients with antibody deficiencies.
Speletas M; Mamara A; Papadopoulou-Alataki E; Iordanakis G; Liadaki K; Bardaka F; Kanariou M; Germenis AE
J Clin Immunol; 2011 Aug; 31(4):550-9. PubMed ID: 21547394
[TBL] [Abstract][Full Text] [Related]
9. TACI mutations and disease susceptibility in patients with common variable immunodeficiency.
Poodt AE; Driessen GJ; de Klein A; van Dongen JJ; van der Burg M; de Vries E
Clin Exp Immunol; 2009 Apr; 156(1):35-9. PubMed ID: 19210517
[TBL] [Abstract][Full Text] [Related]
10. The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function.
Lee JJ; Rauter I; Garibyan L; Ozcan E; Sannikova T; Dillon SR; Cruz AC; Siegel RM; Bram R; Jabara H; Geha RS
Blood; 2009 Sep; 114(11):2254-62. PubMed ID: 19605846
[TBL] [Abstract][Full Text] [Related]
11. Sequence variants of the TNFRSF13B gene in Czech CVID and IgAD patients in the context of other populations.
Freiberger T; Ravčuková B; Grodecká L; Pikulová Z; Stikarovská D; Pešák S; Kuklínek P; Jarkovský J; Salzer U; Litzman J
Hum Immunol; 2012 Nov; 73(11):1147-54. PubMed ID: 22884984
[TBL] [Abstract][Full Text] [Related]
12. TACI, isotype switching, CVID and IgAD.
Castigli E; Geha RS
Immunol Res; 2007; 38(1-3):102-11. PubMed ID: 17917015
[TBL] [Abstract][Full Text] [Related]
13. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency.
Mohammadi J; Liu C; Aghamohammadi A; Bergbreiter A; Du L; Lu J; Rezaei N; Amirzargar AA; Moin M; Salzer U; Pan-Hammarström Q; Hammarström L
J Clin Immunol; 2009 Nov; 29(6):777-85. PubMed ID: 19629655
[TBL] [Abstract][Full Text] [Related]
14. TACI deficiency - a complex system out of balance.
Salzer U; Grimbacher B
Curr Opin Immunol; 2021 Aug; 71():81-88. PubMed ID: 34247095
[TBL] [Abstract][Full Text] [Related]
15. The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice.
Bacchelli C; Buckland KF; Buckridge S; Salzer U; Schneider P; Thrasher AJ; Gaspar HB
J Allergy Clin Immunol; 2011 May; 127(5):1253-9.e13. PubMed ID: 21458042
[TBL] [Abstract][Full Text] [Related]
16. Innate Mechanisms in Selective IgA Deficiency.
Zhang J; van Oostrom D; Li J; Savelkoul HFJ
Front Immunol; 2021; 12():649112. PubMed ID: 33981304
[TBL] [Abstract][Full Text] [Related]
17. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes.
Martinez-Gallo M; Radigan L; Almejún MB; Martínez-Pomar N; Matamoros N; Cunningham-Rundles C
J Allergy Clin Immunol; 2013 Feb; 131(2):468-76. PubMed ID: 23237420
[TBL] [Abstract][Full Text] [Related]
18. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency.
Lee JJ; Jabara HH; Garibyan L; Rauter I; Sannikova T; Dillon SR; Bram R; Geha RS
J Allergy Clin Immunol; 2010 Dec; 126(6):1234-41.e2. PubMed ID: 20889194
[TBL] [Abstract][Full Text] [Related]
19. A novel compound heterozygous TACI mutation in an autosomal recessive common variable immunodeficiency (CVID) family.
Lougaris V; Gallizzi R; Vitali M; Baronio M; Salpietro A; Bergbreiter A; Salzer U; Badolato R; Plebani A
Hum Immunol; 2012 Aug; 73(8):836-9. PubMed ID: 22627058
[TBL] [Abstract][Full Text] [Related]
20. An evolutionary approach to the medical implications of the tumor necrosis factor receptor superfamily member 13B (TNFRSF13B) gene.
Sazzini M; Zuntini R; Farjadian S; Quinti I; Ricci G; Romeo G; Ferrari S; Calafell F; Luiselli D
Genes Immun; 2009 Sep; 10(6):566-78. PubMed ID: 19494827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
